Sign up to our technology alerts and be the first to hear about any new technology opportunities from Scotland's universities
Please select the market sector you are interested in.
Please select the university you are interested in.
Show only Easy Access opportunities.
Narrow your search with a few keywords.
University: University of St Andrews
Sector(s): Life Sciences, Electronics, Sensors & Photonics
Optical microfluidic sorting will allow biological or other matter to be sorted or fractionated by criteria including size, shape, density and refractive index. The technique may have the ability to sort matter from the scale of macro-molecules all the way up to large cells.
In addition to the technical advantages of optical sorting and fractionation, the inherent simplicity of the approach could allow the system to be integrated with the existing laboratory equipment currently found in any research lab or hospital. This method allows a non-invasive technique for the sorting, separation and analysis of biological matter which maintains the "natural" state of the material, in contrast to classical methods of fractionation and sorting including centrifugation, electrophoresis, liquid and solid chromatography and fluorescent and other labelled sorting. These classical techniques often require pre-treatment of biological material or derive an altered product.
Applications include the fractionation, separation or enrichment of biological material and the sorting of a single type of colloidal matter from a polydisperse sample. The technology is compatible with the areas of microfluidics and nanotechnology.
The technology with non-invasive functionality allows integration and miniaturization into microanalysis systems ("lab-on-chip").
Optical sorting and fractionation also have applications where gel electrophoresis, centrifuging and FACS are currently methods of choice. Typical future users will be developing novel micromachines, colloids and bio-engineering processes etc
The University of St Andrews has applied for UK and international patent protection and the research group involved continues to perform R&D in microfluidic sorting. There are no commercial parties involved in this research and the University would welcome enquiries from commercial parties interested in developing commercial applications of optical sorting and fractionating.
Please enter your name.
Please enter the name of the company you work for.
Is your company an SME?
Please select the country you are in.
Please enter your email address.
Please enter your telephone number.
To help us process your enquiry faster please enter some details about the information you are interested in.
Please prove you are a human by completing this simple image recognition task.
Bisnaphthalimido derivatives exhibit considerable potential as cytotoxic agents for cancer therapy. We have created a number of new bisnapthalimidopropyl derivatives which feature polyamine linkers between the bisnapthalimidopropyl fragments. Compared to previous derivatives, the new compounds have ...
Bisnaphthalimido derivatives exhibit considerable potential as cytotoxic agents for cancer therapy. To realise this potential, we have created a number of new bisnapthalimidopropyl derivatives which feature polyamine linkers between the bisnapthalimidopropyl fragments. Compared to previous derivativ...
Heriot-Watt has demonstrated a lens & software system that images and tracks live cells, cell processes and small particles in real time in 3D.
Compatible with existing microscopes, this technology is available for license, development or purchase for use in microscopy applications such as fluor...
Combining the sequential use of 2 enzymes – fluorinase and nucleoside hydrolase – we have successfully produced a new radiotracer with potential as an imaging biomarker for PET scans. The fluorinase enzyme combines fluorine with S-adenosyl-L-methionine (SAM) to generate 5'-fluro-5'-deoxy...
We have engineered a panel of recombinant proteins that have up to nanomolar affinity forsialic acid and bind to cell surfaces. They are designed to mask the receptors of the influenza(and parainfluenza) virus in the respiratory tract. The recombinant therapeutic proteins areeasily produced and puri...